Home | Welcome to Contract Pharma   
Last Updated Sunday, December 28 2014

Print

Search Results for 'preclinical cro'

Search For:
Refine by Dates:
From: To:
Past 7 Days        Past 30 Days
Refine By Content:

Search Results:

Characterizing the Cost of Non-Clinical Development Activity
By Stella Stergiopoulos, Jennifer Kim, Kenneth Getz, Tufts CSDD
Published June 5, 2013
Understanding a critical R&D segment Read More »
By Gil Roth
Published April 20, 2012
Will offer integrated "bench-to-bedside" services Read More »
By Steve Snyder, Contributing Editor
Published March 7, 2012
Positive signs for CROs Read More »
By Steve Snyder
Published October 11, 2011
My answers to Frequently Asked Questions Read More »
Preclinical Outsourcing Report
By Jay Mehta
Published September 7, 2011
Long-term and more collaborative contracts to optimize cost structures Read More »
By Steve Snyder
Published September 7, 2011
The quest to control the uncontrollable Read More »
By Steve Snyder
Published July 13, 2011
Excerpts from some favorite past articles Read More »
By Steve Snyder
Published July 9, 2010
Business at some preclinical CROs starts to rebound Read More »
By Steve Snyder
Published November 3, 2006
Tips for learning to read between the lines Read More »
By Joanna Lewandowska, PR & Marketing Manager

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On